Dry Eye Treatment Devices Market - By Technology (Broadband Light (BBL), Intense Pulsed Light (IPL), Meibomian Gland Expression (MGX), Combination (MGX+IPL)), By End-use (Hospitals, Ophthalmic Clinics), & Forecast, 2023 – 2032
Published Date: August - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationDry Eye Treatment Devices Market - By Technology (Broadband Light (BBL), Intense Pulsed Light (IPL), Meibomian Gland Expression (MGX), Combination (MGX+IPL)), By End-use (Hospitals, Ophthalmic Clinics), & Forecast, 2023 – 2032
Dry Eye Treatment Devices Market Size
Dry Eye Treatment Devices Market size was valued at over USD 260 million in 2022 and is anticipated to grow at a CAGR of 8.4% between 2023 and 2032. This incremental growth rate is owing to increasing prevalence of dry eye disease coupled with technological advancements in dry eye treatment devices. Increasing number of contact lens wearers associated with growing usage of visual display terminals is anticipated to drive the dry eye treatment devices industry expansion.
Hey there! You've probably heard of dry eye disease, right? Well, it's becoming even more common these days, thanks to all the time we spend staring at screens and getting older. But don't worry, doctors are starting to understand how important it is to treat this condition early on. And because so many people need help with this, companies are working hard to create new treatments. They're coming up with all sorts of cool devices that are really making a difference in people's lives. As more people learn about dry eye disease, even more of us are asking for these treatments. And that's great news! Because it means companies will keep improving their devices and making them even better. So, if you're struggling with dry eyes, know that there are treatments available and that the future looks bright.
Dry eye treatment devices are medical devices designed to alleviate the symptoms and address the underlying causes of dry eye syndrome. Dry eye treatment devices employ various technologies and approaches to improve tear production, enhance tear quality, and provide relief from dry eye symptoms.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Dry Eye Treatment Devices Market Size in 2022 | USD 261 Million |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 8.4% |
| 2032 Value Projection | USD 586 Million |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 130 |
| Tables, Charts & Figures | 195 |
| Segments covered | Technology, End-use, and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
But there's a catchsome people can't use these devices because of certain conditions they have. These conditions are called contraindications. For example, some people have sensitive or easily irritated skin, so using intense pulsed light (IPL) devices for dry eyes isn't a good fit for them. Also, if someone has glaucoma, cataracts, or other eye problems, IPL treatment could actually make things worse. So, even though these devices can help some people with dry eyes, they're not for everyone.
Certain medications or medical conditions, such as photosensitivity disorders, can contraindicate the use of IPL devices. Patients with a history of adverse reactions to light-based treatments or those taking medications that increase sensitivity to light are advised against IPL treatment. Therefore, the aforementioned factors and contraindications can limit the eligibility of certain patients for the usage of dry eye treatment devices, thereby rendering a negative impact over the market growth.
COVID-19 Impact
The COVID-19 pandemic has upended the way people with dry eye syndrome get the care they need. When the virus surged in early 2020, it threw a curveball into healthcare systems. Hospitals and clinics were flooded with COVID-19 patients, leading to a sharp decline in appointments for dry eye and other eye conditions. Many non-urgent procedures, including surgeries, had to be put on hold. To add to the challenges, the pandemic disrupted global supply chains. This meant that manufacturers had trouble producing and shipping dry eye treatment devices. People who relied on these devices had to endure long delays in getting them. The impact of the pandemic has been felt by people with dry eye syndrome worldwide.
The COVID-19 pandemic really shook things up for businesses everywhere. Lockdowns, travel bans, and not enough workers made it hard for companies to keep up with the number of products people wanted, so there weren't enough things to go around and businesses couldn't grow as fast. For eye care, the pandemic kept people away from their doctors' offices and eye clinics. That meant fewer people were getting their eyes checked and getting the treatment they needed, so there was less demand for devices that help with dry eye. It was also harder for people to get in touch with eye doctors and get these devices when they needed them. So, the pandemic was a real setback for the market for devices that treat dry eye in 2020. But things started to get better in 2021 as the situation improved and more people started seeing their doctors again. As things keep getting better and more people get the treatment they need, this market is expected to keep growing in the years to come.
Dry Eye Treatment Devices Market Trends
Imagine you're talking to your friend about dry eye disease. Here's how you could explain it in a friendly, conversational way"Hey, you know how dry eye is becoming more common? It's especially a problem for older folks. Like, in 2022, over 344 million people around the world had it! And guess what? That number is only expected to keep climbing. Now, here's the good news. There are devices that can help soothe those annoying symptoms like dryness, burning, redness, and that awful itch. These gadgets can even help bring back your eyes' natural moisture level. And here's why this is a big dealolder people are more prone to dry eye because their bodies don't produce as many tears and the tears they do make aren't as good anymore. So, as more and more people develop dry eye, the need for these devices will keep growing, which means the market for them is going to boom!"
Hey, have you noticed how glued we are to our phones, laptops, and tablets these days? It's like they're an extension of ourselves. But guess what? That constant screen time can mess with our eyes. You know how we blink less when we're staring at a screen? That's not good for our eyes, it can make them dry and irritated. With so many of us relying on these devices, more and more people are getting dry eye disease. It's no joke. But the good news is that doctors have been working hard to figure out better ways to diagnose and treat it. Now we have awesome tools to spot dry eye disease and come up with personalized treatments. These treatments can make our eyes feel better and keep them healthy. So, if you're feeling that dry, scratchy sensation in your eyes, don't ignore it. Talk to your doctor, and together you can find the best way to keep your eyes in tip-top shape.
Dry Eye Treatment Devices Market Analysis
If you're struggling with dry, irritated eyes, you might be curious about eye treatment devices. There are a few different options out there, but one of the most popular is something called meibomian gland expression (MGX). MGX targets a common cause of dry eyes called meibomian gland dysfunction (MGD). You see, your eyelids have tiny glands called meibomian glands that produce an oily layer that helps keep your tears from drying out too quickly. But sometimes, these glands get clogged or don't work as well as they should, and your tears start to get watery and evaporate too fast. That's where MGX comes in. It's a device that gently squeezes out the blockages in your meibomian glands. This helps the healthy oils flow again, which improves the quality of your tears and gives them a chance to keep your eyes moist and comfortable.
MGX promotes more stable tears, reducing dryness, irritation, and fluctuations in vision associated with dry eye disease. Regular and proactive use of Meibomian gland expression can help prevent the progression of meibomian gland dysfunction and associated dry eye symptoms. By maintaining the health and function of the meibomian glands, MGX can help prevent future blockages and minimize the risk of developing severe dry eye disease. Therefore, owing to several benefits offered by meibomian gland expression (MGX), the market is estimated to witness a significant growth in the coming years.
When your eyes feel dry and uncomfortable, hospitals are the ultimate destination for relief. They house an arsenal of cutting-edge technologies and tools designed to soothe your dry eyes and address any underlying issues. Picture thisa patient struggling with dry eye visits a specialized eye care unit in a hospital. The unit is equipped with the latest diagnostic marvels, allowing experts to pinpoint the root cause of their discomfort. Armed with this knowledge, doctors craft a personalized treatment plan that may involve innovative devices specifically designed to alleviate dry eyes. Hospitals are the undisputed leaders in dry eye management because they offer a comprehensive approach. They have the finest doctors and the most advanced equipment to tackle even the most complex cases. So, if dry eyes are dimming your days, seeking refuge in a hospital is the wisest choice you can make.
Hey there! You know how hospitals are usually thought of for emergencies or surgeries? Well, it's not just about that anymore. Hospitals are also the go-to place for treating tricky health issues like dry eye disease. Why? Because they've got everything under one roof! When you have dry eye disease and it's linked to other health problems, you can get all your treatments in one place. Hospitals have teams of doctors, nurses, and other experts who work together to figure out what's going on and come up with the best plan for you. Plus, hospitals have all the latest and greatest equipment. We're talking special devices that use intense light and heat to make your eyes feel better. With all these resources and experts, you're getting the best possible care for your dry eye disease. That's why more folks are choosing to go to the hospital for this condition. It's the smart choice for the best results!
In North America, dry eye treatment devices have taken the spotlight. In 2022, it was a booming $95 million market, thanks to a few key reasonsFirst off, big players in the dry eye game have set up shop in North America. That means we've got access to the latest and greatest treatments. Secondly, more and more people are struggling with dry eyes. Why? As we age, our eyes tend to get a little drier. And let's face it, we're all staring at screens way too much these days, which can also irritate our eyes. Oh, and the climate in some parts of North America can be pretty rough on our eyes too. All these factors have contributed to the surge in dry eye cases. Just in the US alone, around 20 million people were battling dry eyes in 2022. That's a lot of watery, itchy, burning eyes! No wonder the demand for treatments has skyrocketed. And thanks to our access to top-notch technologies like intense pulsed light (IPL), meibomian gland expression (MGX), and combination therapies, North America has become the frontrunner in this market. We've got your dry eyes covered!
It's easier than ever to find relief for dry eyes in North America thanks to the abundance of specialized eye care clinics. These clinics are equipped with the latest and greatest technology, offering a range of treatments for dry eyes. And guess what? Most insurance policies cover these devices, making them more accessible and affordable for those struggling with this condition. As a result, more and more people are stepping forward to seek treatment for dry eyes. Plus, researchers are working hard to develop even better ways to treat this pesky problem, which is only increasing the demand for these devices. So, what's driving this surge in demand? It's a combination of factorsmore people with dry eyes, advanced technology, skilled eye care services, increased awareness, insurance coverage, and ongoing research. Together, these factors are fueling the demand for dry eye treatment devices in North America.
Dry Eye Treatment Devices Market Share
Some of the major players operating in the dry eye treatment devices market are
- Alcon, Allergan (AbbVie)
- BioTissue, Inc
- BlephEx LLC
- ESW Vision
- EyePrint Prosthetics, LLC
- Holbar Medical Products
- Johnson & Johnson Vision
- Lumenis
- Mibo Medical Group
- NuSight Medical,
- Sight Sciences
These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products.
Dry Eye Treatment Devices Industry Leaders
- In April 2022, Alcon announced the launch of Systane iLux2 a meibomian gland dysfunction (MGD) thermal pulsation system. The Systane iLux2 MGD thermal pulsation system is integrated with advance imaging technology to view both meibomian glands and allows practitioners to tailor MGD treatment in 8-12 minutes. This innovative product launch helped the company to enhance their dry eye treatment devices product portfolio and enhance their business revenue.
- In April 2021, Lumenis Ltd. announced that they had received the U.S. FDA approval to launch their OptiLight IPL device for the diagnosis and treatment of dry eye disease. OptiLight is integrated with OPT technology, and offers a consistent, precise, and controlled light-based treatment for dry eye disease. This regulatory approval helped the company to expand their customer base and gain a competitive edge over its peers.
Dry eye treatment devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Million) from 2018 to 2032, for the following segments
Click here to Buy Section of this Report
By Technology
- Broadband light (BBL)
- Intense Pulsed Light (IPL)
- Meibomian Gland Expression (MGX)
- Combination (MGX+IPL)
By End-use
- Hospitals
- Ophthalmic Clinics
- Others
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Poland
- Sweden
- The Netherlands
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Indonesia
- Thailand
- Philippines
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Peru
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Israel
- Egypt
- Turkey
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy